This week, five Medical Devices stocks are improving their overall rating on Portfolio Grader. Each of these rates an “A” (“strong buy”) or “B” overall (“buy”).
RTI Biologics‘s (NASDAQ:RTIX) grade is moving up to a B (“buy”) this week from last week’s C (“hold”). RTI Biologics processes human and animal musculoskeletal tissues in producing allograft and xenograft implants. In Portfolio Grader’s specific subcategories of Earnings Growth and Earnings Surprise, RTIX also gets A’s. The stock price has risen 4.8% over the past month, better than the 3.9% increase the Nasdaq has seen over the same period of time. For more information, get Portfolio Grader’s complete analysis of RTIX stock.
Spectranetics (NASDAQ:SPNC) is making headway this week, with the company’s rating improving to an A (“strong buy”) from a B (“buy”) last week. The Spectranetics Corporation develops, manufactures, markets and distributes single-use medical devices used in minimally invasive procedures within the cardiovascular system, many of which are used with its proprietary excimer laser system. For more information, get Portfolio Grader’s complete analysis of SPNC stock.
Derma Sciences (NASDAQ:DSCI) improves from a C to a B rating this week. Derma Sciences markets and sells a range of skin care, wound management, and specialty securement devices. For more information, get Portfolio Grader’s complete analysis of DSCI stock.
The rating of PhotoMedex (NASDAQ:PHMD) moves up this week, rising from a C to a B. PhotoMedex manufactures excimer laser and fiber-optic systems used to treat dermatological conditions such as psoriasis, vitiligo, atopic dermatitis, and leukoderma. For more information, get Portfolio Grader’s complete analysis of PHMD stock.
This week, Solta Medical‘s (NASDAQ:SLTM) ratings are up from a C last week to a B. Solta Medical designs, develops, manufactures and markets medical devices for the non-invasive treatment of wrinkles. For more information, get Portfolio Grader’s complete analysis of SLTM stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.